Mapping and phenotypic analysis of spontaneous isatin-β-thiosemicarbazone resistant mutants of vaccinia virus

Virology

Volumn 363, Issue 2, 2007, Pages 319-332

  Cresawn, Steven G ^a   Prins, Cindy ^a   Latner, Donald R ^a   Condit, Richard C ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Drug resistance; Genetics; Isatin thiosemicarbazone; Marker rescue; RNA polymerase; Transcription; Vaccinia virus

Indexed keywords

ANTIVIRUS AGENT; ISATIN 3 THIOSEMICARBAZONE; RNA POLYMERASE; RPO 132 ENZYME; RPO 147 ENZYME; TRANSCRIPTION ELONGATION FACTOR; UNCLASSIFIED DRUG;

A24R GENE; ANIMAL CELL; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; G2R GENE; GENE MAPPING; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; J6R GENE; MISSENSE MUTATION; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; SEQUENCE ANALYSIS; VACCINIA VIRUS; VIRUS CULTURE; VIRUS GENE; VIRUS GENOME; VIRUS ISOLATION; VIRUS MUTANT; VIRUS RESISTANCE;

ANIMALS; CATALYTIC DOMAIN; CELL LINE; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, VIRAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; HUMANS; ISATIN; MODELS, CHEMICAL; MUTATION; PEPTIDE ELONGATION FACTORS; PHENOTYPE; RNA, MESSENGER; RNA, VIRAL; TRANSCRIPTIONAL ELONGATION FACTORS; VACCINIA VIRUS; VIRAL PROTEINS;

VACCINIA VIRUS;

EID: 34248515264     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.02.005     Document Type: Article

References (57)

1. Ahn B.Y., and Moss B. RNA polymerase-associated transcription specificity factor encoded by vaccinia virus. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 3536-3540
2. Ahn B.Y., Gershon P.D., Jones E.V., and Moss B. Identification of rpo30, a vaccinia virus RNA polymerase gene with structural similarity to a eucaryotic transcription elongation factor. Mol. Cell Biol. 10 (1990) 5433-5441
3. Batada N.N., Westover K.D., Bushnell D.A., Levitt M., and Kornberg R.D. Diffusion of nucleoside triphosphates and role of the entry site to the RNA polymerase II active center. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 17361-17364
4. Bayliss C.D., and Condit R.C. Temperature-sensitive mutants in the vaccinia virus A18R gene increase double-stranded RNA synthesis as a result of aberrant viral transcription. Virology 194 (1993) 254-262
5. Bayliss C.D., and Condit R.C. The vaccinia virus A18R gene product is a DNA-dependent ATPase. J. Biol. Chem. 270 (1995) 1550-1556
6. Black E.P., and Condit R.C. Phenotypic characterization of mutants in vaccinia virus gene G2R, a putative transcription elongation factor. J. Virol. 70 (1996) 47-54
7. Black E.P., Moussatche N., and Condit R.C. Characterization of the interactions among vaccinia virus transcription factors G2R, A18R, and H5R. Virology 245 (1998) 313-322
8. Broyles S.S. Vaccinia virus transcription. J.Gen.Virol. (2003) on line. 2003. Ref Type: Generic
9. Broyles S.S., and Moss B. Homology between RNA polymerases of poxviruses, prokaryotes, and eukaryotes: nucleotide sequence and transcriptional analysis of vaccinia virus genes encoding 147-kDa and 22-kDa subunits. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 3141-3145
10. Christen L.M., Sanders M., Wiler C., and Niles E.G. Vaccinia virus nucleoside triphosphate phosphohydrolase I is an essential viral early gene transcription termination factor. Virology 245 (1998) 360-371
11. Cohrs R.J., Condit R.C., Pacha R.F., Thompson C.L., and Sharma O.K. Modulation of ppp(A2'p)nA-dependent RNase by a temperature-sensitive mutant of vaccinia virus. J.Virol. 63 (1989) 948-951
12. Condit R.C., and Niles E.G. Regulation of viral transcription elongation and termination during vaccinia virus infection. Biochim. Biophys. Acta 1577 (2002) 325-336
13. Condit R.C., and Motyczka A. Isolation and preliminary characterization of temperature-sensitive mutants of vaccinia virus. Virology 113 (1981) 224-241
14. Condit R.C., Motyczka A., and Spizz G. Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus. Virology 128 (1983) 429-443
15. Condit R.C., Easterly R., Pacha R.F., Fathi Z., and Meis R.J. A vaccinia virus isatin-beta-thiosemicarbazone resistance mutation maps in the viral gene encoding the 132-kDa subunit of RNA polymerase. Virology 185 (1991) 857-861
16. Condit R.C., Lewis J.I., Quinn M., Christen L.M., and Niles E.G. Use of lysolecithin-permeabilized infected-cell extracts to investigate the in vitro biochemical phenotypes of poxvirus ts mutations altered in viral transcription activity. Virology 218 (1996) 169-180
17. Condit R.C., Xiang Y., and Lewis J.I. Mutation of vaccinia virus gene G2R causes suppression of gene A18R ts mutants: implications for control of transcription. Virology 220 (1996) 10-19
18. Cooper J.A., Wittek R., and Moss B. Extension of the transcriptional and translational map of the left end of the vaccinia virus genome to 21 kilobase pairs. J. Virol. 39 (1981) 733-745
19. Cramer P., Bushnell D.A., Fu J., Gnatt A.L., Maier-Davis B., Thompson N.E., Burgess R.R., Edwards A.M., David P.R., and Kornberg R.D. Architecture of RNA polymerase II and implications for the transcription mechanism. Science 288 (2000) 640-649
20. Cramer P., Bushnell D.A., and Kornberg R.D. Structural basis of transcription: RNA polymerase II at 2.8 angstrom resolution. Science 292 (2001) 1863-1876
21. Deng L., and Shuman S. A role for the H4 subunit of vaccinia RNA polymerase in transcription initiation at a viral early promoter. J. Biol. Chem. 269 (1994) 14323-14328
22. Deng L., and Shuman S. Vaccinia NPH-I, a DExH-box ATPase, is the energy coupling factor for mRNA transcription termination. Genes Dev. 12 (1998) 538-546
23. Esposito J., Condit R., and Obijeski J. The preparation of orthopoxvirus DNA. J. Virol. Methods 2 (1981) 175-179
24. Fu J., Gnatt A.L., Bushnell D.A., Jensen G.J., Thompson N.E., Burgess R.R., David P.R., and Kornberg R.D. Yeast RNA polymerase II at 5 A resolution. Cell 98 (1999) 799-810
25. Gershon P.D., Ahn B.Y., Garfield M., and Moss B. Poly(A) polymerase and a dissociable polyadenylation stimulatory factor encoded by vaccinia virus. Cell 66 (1991) 1269-1278
26. Hagler J., and Shuman S. Nascent RNA cleavage by purified ternary complexes of vaccinia RNA polymerase. J. Biol. Chem. 268 (1993) 2166-2173
27. Katz E., Margalith E., and Winer B. An isatin beta-thiosemicarbazone (IBT)-dependent mutant of vaccinia virus: the nature of the IBT-dependent step. J. Gen. Virol. 21 (1973) 477-484
28. Katz E., Winer B., Margalith E., and Goldblum N. Isolation and characterization of an IBT-dependent mutant of vaccinia virus. J. Gen. Virol. 19 (1973) 161-164
29. Kettenberger H., Armache K.J., and Cramer P. Architecture of the RNA polymerase II-TFIIS complex and implications for mRNA cleavage. Cell 114 (2003) 347-357
30. Klug A. Structural biology. A marvelous machine for making messages. Science 292 (2001) 1844-1846
31. Kovacs G.R., and Moss B. The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression. J. Virol. 70 (1996) 6796-6802
32. Lackner C.A., and Condit R.C. Vaccinia virus gene A18R DNA helicase is a transcript release factor. J. Biol. Chem. 275 (2000) 1485-1494
33. Lackner C.A., D'Costa S.M., Buck C., and Condit R.C. Complementation analysis of the Dales collection of vaccinia virus temperature-sensitive mutants. Virology 305 (2003) 240-259
34. Latner D.R., Xiang Y., Lewis J.I., Condit J., and Condit R.C. The vaccinia virus bifunctional gene J3 (nucleoside-2′-O-)-methyltransferase and poly(A) polymerase stimulatory factor is implicated as a positive transcription elongation factor by two genetic approaches. Virology 269 (2000) 345-355
35. Latner D.R., Thompson J.M., Gershon P.D., Storrs C., and Condit R.C. The positive transcription elongation factor activity of the vaccinia virus J3 protein is independent from its (nucleoside-2′-O-) methyltransferase and poly(A) polymerase stimulatory functions. Virology 301 (2002) 64-80
36. Luttge B.G., and Moyer R.W. Suppressors of a host range mutation in the rabbitpox virus serpin SPI-1 map to proteins essential for viral DNA replication. J. Virol. 79 (2005) 9168-9179
37. Mahr A., and Roberts B.E. Arrangement of late RNAs transcribed from a 7.1-kilobase EcoRI vaccinia virus DNA fragment. J. Virol. 49 (1984) 510-520
38. McCraith S., Holtzman T., Moss B., and Fields S. Genome-wide analysis of vaccinia virus protein-protein interactions. Proc. Natl. Acad. Sci. U.S.A 97 (2000) 4879-4884
39. Meis R.J., and Condit R.C. Genetic and molecular biological characterization of a vaccinia virus gene which renders the virus dependent on isatin-beta-thiosemicarbazone (IBT). Virology 182 (1991) 442-454
40. Mohamed M.R., and Niles E.G. Interaction between nucleoside triphosphate phosphohydrolase I and the H4L subunit of the viral RNA polymerase is required for vaccinia virus early gene transcript release. J. Biol. Chem. 275 (2000) 25798-25804
41. Moss B. Poxviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology (2001), Lippincott Williams and Wilkins, Philadelphia 2849-2884
42. Opalka N., Chlenov M., Chacon P., Rice W.J., Wriggers W., and Darst S.A. Structure and function of the transcription elongation factor GreB bound to bacterial RNA polymerase. Cell 114 (2003) 335-345
43. Pacha R.F., and Condit R.C. Characterization of a temperature-sensitive mutant of vaccinia virus reveals a novel function that prevents virus-induced breakdown of RNA. J. Virol. 56 (1985) 395-403
44. Pacha R.F., Meis R.J., and Condit R.C. Structure and expression of the vaccinia virus gene which prevents virus-induced breakdown of RNA. J. Virol. 64 (1990) 3853-3863
45. Prins C., Cresawn S.G., and Condit R.C. An isatin-beta-thiosemicarbazone-resistant vaccinia virus containing a mutation in the second largest subunit of the viral RNA polymerase is defective in transcription elongation. J. Biol. Chem. 279 (2004) 44858-44871
46. Reines D., Ghanouni P., Gu W., Mote Jr. J., and Powell W. Transcription elongation by RNA polymerase II: mechanism of SII activation. Cell Mol. Biol. Res. 39 (1993) 331-338
47. Schnierle B.S., Gershon P.D., and Moss B. Cap-specific mRNA (nucleoside-O2′-)-methyltransferase and poly(A) polymerase stimulatory activities of vaccinia virus are mediated by a single protein. Proc. Natl. Acad. Sci. U.S.A 89 (1992) 2897-2901
48. Schwer B., Visca P., Vos J.C., and Stunnenberg H.G. Discontinuous transcription or RNA processing of vaccinia virus late messengers results in a 5′ poly(A) leader. Cell 50 (1987) 163-169
49. Shuman S., Broyles S.S., and Moss B. Purification and characterization of a transcription termination factor from vaccinia virions. J. Biol. Chem. 262 (1987) 12372-12380
50. Simpson D.A., and Condit R.C. Vaccinia virus gene A18R encodes an essential DNA helicase. J. Virol. 69 (1995) 6131-6139
51. Toulme F., Mosrin-Huaman C., Sparkowski J., Das A., Leng M., and Rahmouni A.R. GreA and GreB proteins revive backtracked RNA polymerase in vivo by promoting transcript trimming. EMBO J. 19 (2000) 6853-6859
52. Wright C.F., and Coroneos A.M. The H4 subunit of vaccinia virus RNA polymerase is not required for transcription initiation at a viral late promoter. J. Virol. 69 (1995) 2602-2604
53. Xiang, Y., 1998. PhD Thesis.
54. Xiang Y., Simpson D.A., Spiegel J., Zhou A., Silverman R.H., and Condit R.C. The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor. J. Virol. 72 (1998) 7012-7023
55. Xiang Y., Latner D.R., Niles E.G., and Condit R.C. Transcription elongation activity of the vaccinia virus J3 protein in vivo is independent of poly(A) polymerase stimulation. Virology 269 (2000) 356-369
56. Yuen L., and Moss B. Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 6417-6421
57. Zaychikov E., Martin E., Denissova L., Kozlov M., Markovtsov V., Kashlev M., Heumann H., Nikiforov V., Goldfarb A., and Mustaev A. Mapping of catalytic residues in the RNA polymerase active center. Science 273 (1996) 107-109